Navigation Links
Novogen and Marshall Edwards Sign Asset Purchase Agreement
Date:12/21/2010

SYDNEY and SAN DIEGO, Dec. 21, 2010 /PRNewswire-FirstCall/ -- Novogen Limited and Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today that they have entered into a definitive asset purchase agreement pursuant to which Marshall Edwards will acquire Novogen's isoflavone-based intellectual property portfolio in exchange for $4 million of convertible preferred stock.

"Over the past fifteen years, Novogen has conducted the largest and most comprehensive isoflavone-based research program in the world," said William D. Rueckert, Chairman of Novogen's Board of Directors. "We believe these assets are now better served in the hands of a company equipped with the drug development expertise and access to capital required to execute a clinical strategy and fully realize their value. Meanwhile, this transaction serves to bolster our ownership stake in Marshall Edwards, a significant value driver for our company going forward."

"This agreement represents the culmination of a watershed year at Marshall Edwards," said Professor Bryan Williams, Ph.D., Chairman of Marshall Edwards' Board of Directors. "Now armed with a hand-selected management team, world-class oncology drug development expertise and the flexibility to develop these valuable assets, we are poised to enter the clinic with two next-generation drug candidates in the coming year. In addition, this strategic acquisition will enable us to explore other potential candidates and indications within the portfolio while enhancing our ability to partner."

Utilizing a novel isoflavone-based technology platform, researchers at Novogen have generated more than 400 new chemical structures, including a number of compounds that have demonstrated robust anti-tumor activity in cancer cells. Previously, Marshall Edwards licen
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Marshall Edwards CEO to Present at Lazard Capital Markets Healthcare Conference
2. Marshall Edwards CEO to Present at JMP Securities Healthcare Conference
3. Nobel Prize Winner Robert Edwards: A Personal Memoir by the Only American Physician to Participate in Developing IVF
4. Protege of Nobel Prize Winner Robert Edwards Carries on his IVF Legacy
5. Solutia Announces Sale of Perkalink® Business and Select Primary Accelerators Assets
6. Private Sector Investment in Agriculture Emerging as a Significant Alternative Asset Class: New HighQuest Partners Study
7. Genaera Liquidating Trust To Sell Remaining Proprietary Assets
8. OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock
9. Pharmasset to Webcast an Investor Event from the AASLD Meeting
10. Corgenix Secures $1,750,000 Asset Based Credit Facility Representing Initial Gross Proceeds of $1.109 Million
11. Gen-Probe to Consolidate Industrial Assets Into New, Independent Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013 •    First of its ... for sustainability ,     New facility will help solve ... , Syngenta unveiled its new crop research ... company’s RTP Innovation Center. The first of its kind, ... simulate any agricultural climate and precisely measure plant inputs ...
(Date:5/17/2013)... 2013  Cellular Biomedicine Group (OTCQB: CBMG) today ... the total projected enrollment required for its Phase ... efficacy of the medical technology haMPC (Human Adipose-derived ... To date the trial has had no Severe ... I open label clinical research trial for KOA, ...
(Date:5/17/2013)... Calif. , May 17, 2013 /PRNewswire-iReach/ -- ... has been reached with Switzerland ... of anti-infective human monoclonal antibody (mAb) products, and ... human mAb products for treatment of infections by ... Staphylococcus aureus , Pseudomonas aeruginosa , ...
(Date:5/17/2013)... 2013 Men’s skin is biologically different than ... ) and has been known to react more aggressively when ... be far from puberty, other acne causing factors like P.acnes ... and threatening skin with unsightly acne scars. Adult acne treatment, ... Health on how to reduce and prevent acne scarring. ...
Breaking Biology Technology:Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2
... Decision Resources, one of the world,s leading research and advisory ... uptake of marketed and emerging TNF-alpha inhibitors and interleukin inhibitors ... billion in 2008 to $5.2 billion in 2018 in the ... Japan. , The new Pharmacor report entitled ...
... ... and related products. Wide range of new peptide synthesis reagents and catalogue peptides. New ... , ... October 22, 2009 -- Mimotopes Pty Ltd, a subsidiary of Commonwealth Biotechnologies Inc. (NASDAQ ...
... , MONTREAL, Oct. 23 /PRNewswire/ - Enerkem, a leading ... Corporate Knights 2009 Next 10 Emerging Cleantech Leaders. Vincent ... the other Cleantech companies at today,s Toronto Stock Exchange ... Cleantech Next 10 list features Canada,s best privately held ...
Cached Biology Technology:Continued Uptake of TNF-Alpha Inhibitors and Interleukin Inhibitors Will Drive $2.2 Billion Growth in the Psoriasis Drug Market 2Mimotopes Launches Online Peptide Superstore 2Mimotopes Launches Online Peptide Superstore 3Enerkem Named an Emerging Cleantech Leader in Canada 2
(Date:5/16/2013)... us don,t ponder our pulses outside of the gym. But ... monitor heart health. , Zhenan Bao, a professor of chemical ... a dollar bill and no wider than a postage stamp. ... the wrist, is sensitive enough to help doctors detect stiff ... be used to continuously track heart health and provide doctors ...
(Date:5/16/2013)... May 16, 2013 The consultancy ... on Tuesday to Germany,s largest ... border control system. DERMALOG has been honored ... Practices Award in the category Global Biometrics and Border ... Biometric   Border Control System . One of ...
(Date:5/15/2013)... that have powerful behavioral effects on diverse organisms ... ecosystems, according to a theory proposed in the ... of the theory, Ryan P. Ferrer of Seattle ... University of California at Los Angeles, liken such ... may be uncommon but exert a controlling influence, ...
Breaking Biology News(10 mins):Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4Natural 'keystone molecules' punch over their weight in ecosystems 2
... Partnership, in partnership with the LUNGevity Foundation, is pleased ... grant competition. The research grants, each $100,000, ... biology, risk assessment, prevention, detection, and response to treatment. ... generous donors, were able to offer researchers critical funding ...
... LAKE CITY Two major eye diseases and leading causes ... or even prevented by drugs that activate a protein ... of Utah School of Medicine and several other institutions ... both diseases was prevented and even reversed when the ...
... a systems biological analysis of genome-scale data from ... researchers identified that the master gene controlling the ... study will appear in the latest issue of ... This hypothesis derived from multi-network analysis of Arabidopsis ...
Cached Biology News:National Lung Cancer Partnership and LUNGevity Foundation 2Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 2Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 3Systems biology approach identifies nutrient regulation of biological clock in plants 2
...
Rabbit polyclonal to Quinolinic acid ( Abpromise for all tested applications). Antigen: Synthetic quinolinic acid conjugated to bovine serum albumin....
Human Cell Line Slides...
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile...
Biology Products: